No. 1 (2023): January-February
19-20
2023-02-27
Open Access

LABORATORY DIAGNOSTICS OF GENETIC PREDICTORS OF HOMOCYSTEINE IN THE DEVELOPMENT OF MIGRAINE

Kambarova Dildora Nohidbekovna
Usmanova Durdona Jurabaevna
DOI: https://doi.org/10.56121/2181-3612-2023-1-19-20

Received: 2023-08-06 15:01:45

Published: 2023-02-27

PDF (Russian)
Crossmark Crossmark

Abstract

The article studied various options for the development of the pathogenesis of migraine. In addition to the aforementioned pathogenesis, another homocysteine-related migraine hypothesis has emerged, i.e. elevated homocysteine ​​concentration reduces glutathione production with subsequent oxidative stress and oxidation of homocysteine.

Keywords

List of references

  1. Tommaso MD, Losito L, Livrea P. The role of homocysteine in the pathogenesis and development of migraine. Cephalalgia 2005; 25: 823– 1020.

  2. Lea A, Menon S, Colson NJ et al. Analysis of the MTHFR C677T variant with migraine phenotypes. BMC Res. Notes 2010; 3: 213.

  3. Gavgani SC, Hoseinian MM. Comparative study on homocysteine levels in migraine patients and normal peoples. Ann. Biol. Res. 2012; 3(4): 1804– 7.

  4. Hosseini M, Houshmad M, Ebraini A. MTHFR polymorphism and breast cancer risk. Arch. Med. Sci. 2011; 7: 134– 7.

  5. Antoniades C, Shirodaria C, Leeson P et al. MTHFR 677 C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, no homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 2009; 119: 2507– 15.

  6. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetatrahydrofolate reductase gene is generic risk factor for migraine. Am. J. Med. Genet. 2000; 96: 762– 4.

  7. Lorenz AL, Kahre T, Mihailov E et al. Are methylenetetrahydrofolate reductase (MTHFR) gene polymorphism C677T and A1298 C associated with higher risk of pediatric migraine in boys and girls? J. Biom. Sci. Eng. 2014; 7: 464– 72.

  8. Liu R, Geng P, Ma M et al. MTHFR C677T ploymorfism and migraine risk: a meta-analysis. J. Neurol. Sci. 2014; 336: 68– 73.

  9. Moskowitz MA. The neurobiology of vascular head pain. Ann. Neurol. 1984; 16: 157– 68.

  10. Lea R, Colson N, Quinlan S, McMillan J, Griffiths L. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenet. Genomics 2009; 19: 422– 8.

  11. Shaik MM, Gan SH. Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine. BioMed. Res. Intern. 2015. https://doi.org/10.1155/2015/469529

  12. Tchantchou F, Graves M, Falcone D, Shea TB. S-adenosyl-methionine mediates glutathione efficacy by increasing glutathione-S-transferase activity: implications for the S-adenosylmethionine as a protective dietary activity supplement. J. Alzheimer Dis. 2008; 14: 323– 8.

  13. Boldyrev AA. Molecular mechanisms of homocysteine toxicity. Biochem. (Moscow) 2009; 74: 589– 98.

  14. Cararo JH, Streck EL, Schuck PF, Ferreira C. Carnosine and related peptides: potential in age-related disorders. Aging. Dis. 2015; 5: 369– 79.

About the Authors

Kambarova Dildora Nohidbekovna
durdona.usmanova@mail.ru
Andijan State Medical Institute
Usmanova Durdona Jurabaevna
durdona.usmanova@mail.ru
Tashkent Pediatric Medical Institute

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

1.
LABORATORY DIAGNOSTICS OF GENETIC PREDICTORS OF HOMOCYSTEINE IN THE DEVELOPMENT OF MIGRAINE. MSU [Internet]. 2023 Feb. 27 [cited 2026 Mar. 2];(1):19-20. Available from: https://fdoctors.uz/index.php/journal/article/view/40
Crossref
Scopus
Google Scholar
Europe PMC

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)


ISSN 2181-3612 (Online)